Evidence map›Paper›PMID 35324890›Full record

ArticlePLoS computational biology2022

Isotope-assisted metabolic flux analysis as an equality-constrained nonlinear program for improved scalability and robustness.

Daniel J Lugar, Ganesh Sriram

Abstract read
In one paragraph

Article in PLoS computational biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Metabolic flux analysis in adipose tissue reprogramming.Immunometabolism (Cobham, Surrey) · 2024
    Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Daniel J LugarDepartment of Chemical and Biomolecular Engineering, University of Maryland, College Park, Maryland, United States of America.ORCID 0000-0002-0943-9066
Ganesh SriramDepartment of Chemical and Biomolecular Engineering, University of Maryland, College Park, Maryland, United States of America.ORCID 0000-0002-6303-1328

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stable isotope-assisted metabolic flux analysis (MFA) is a powerful method to estimate carbon flow and partitioning in metabolic networks. At its core, MFA is a parameter estimation problem wherein the fluxes and metabolite pool sizes are model parameters that are estimated, via optimization, to account for measurements of steady-state or isotopically-nonstationary isotope labeling patterns. As MFA problems advance in scale, they require efficient computational methods for fast and robust convergence. The structure of the MFA problem enables it to be cast as an equality-constrained nonlinear program (NLP), where the equality constraints are constructed from the MFA model equations, and the objective function is defined as the sum of squared residuals (SSR) between the model predictions and a set of labeling measurements. This NLP can be solved by using an algebraic modeling language (AML) that offers state-of-the-art optimization solvers for robust parameter estimation and superior scalability to large networks. When implemented in this manner, the optimization is performed with no distinction between state variables and model parameters. During each iteration of such an optimization, the system state is updated instead of being calculated explicitly from scratch, and this occurs concurrently with improvement in the model parameter estimates. This optimization approach starkly contrasts with traditional "shooting" methods where the state variables and model parameters are kept distinct and the system state is computed afresh during each iteration of a stepwise optimization. Our NLP formulation uses the MFA modeling framework of Wiechert et al. [1], which is amenable to incorporation of the model equations into an NLP. The NLP constraints consist of balances on either elementary metabolite units (EMUs) or cumomers. In this formulation, both the steady-state and isotopically-nonstationary MFA (inst-MFA) problems may be solved as an NLP. For the inst-MFA case, the ordinary differential equation (ODE) system describing the labeling dynamics is transcribed into a system of algebraic constraints for the NLP using collocation. This large-scale NLP may be solved efficiently using an NLP solver implemented on an AML. In our implementation, we used the reduced gradient solver CONOPT, implemented in the General Algebraic Modeling System (GAMS). The NLP framework is particularly advantageous for inst-MFA, scaling well to large networks with many free parameters, and having more robust convergence properties compared to the shooting methods that compute the system state and sensitivities at each iteration. Additionally, this NLP approach supports the use of tandem-MS data for both steady-state and inst-MFA when the cumomer framework is used. We assembled a software, eiFlux, written in Python and GAMS that uses the NLP approach and supports both steady-state and inst-MFA. We demonstrate the effectiveness of the NLP formulation on several examples, including a genome-scale inst-MFA model, to highlight the scalability and robustness of this approach. In addition to typical inst-MFA applications, we expect that this framework and our associated software, eiFlux, will be particularly useful for applying inst-MFA to complex MFA models, such as those developed for eukaryotes (e.g. algae) and co-cultures with multiple cell types.

Indexed as

Leukemia, Myeloid, AcuteMetabolic Flux AnalysisCarbon IsotopesHumansIsotope LabelingMetabolic Networks and PathwaysModels, BiologicalCarbon Isotopes

Identifiers

PMID35324890
PMCPMC8947808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.